Masan's Nyobolt Stake Valued at $1B After $60M Fundraise

Overview

Masan Group’s subsidiary, Masan High-Tech Materials (MSR), partially reversed impairment provisions on its investment in Nyobolt after the UK battery startup raised $60 million at a $1 billion valuation in May 2026. The valuation marks a significant increase from the $400 million valuation at the time of Masan’s initial investment in 2022. The partial reversal signals improved prospects for Nyobolt, which develops ultra-fast charging lithium-ion batteries using MSR’s tungsten materials.

Key Facts

• Masan High-Tech Materials (MSR) holds a 15% stake in Nyobolt, acquired in July 2022 for 45 million pounds (52 million euros) via its subsidiary H.C. Starck Tungsten GmbH (HCS).
• Nyobolt raised $60 million in May 2026 at a $1 billion valuation, up from $400 million at Masan’s initial investment.
• MSR partially reversed impairment provisions on the Nyobolt investment in Q2 2026, citing improved cash flow and business plans.
• In 2024, Masan recorded VND 919 billion in impairment provisions for Nyobolt; in 2025, an additional VND 1,261 billion was provisioned.
• In May 2024, MSR reached a framework agreement to sell 100% of H.C. Starck Holding, but HCS transferred its Nyobolt investment to Masan subsidiary The SHERPA for $19.8 million before liquidation.
• Nyobolt demonstrated a concept EV in July 2023 with a 6-minute full charge and has signed agreements with two major commercial customers.
• MSR shares closed at VND 35,700 on July 29, 2026, on the UPCOM exchange.

What Happened

On July 29, 2026, during a Q2 2026 investor meeting, Masan Group CFO Doan Thi My Duyen disclosed that Nyobolt had successfully raised $60 million in May 2026 at a $1 billion valuation. This valuation is 2.5 times higher than the $400 million valuation when Masan first invested via H.C. Starck Tungsten GmbH in July 2022. The improved valuation and better cash flow and business plans provided the basis for Masan to partially reverse impairment provisions on the investment.

Masan emphasized that only a partial reversal was made to maintain conservative accounting principles, as the valuation increase stems from a single transaction. The investment was transferred from HCS to Masan subsidiary The SHERPA for $19.8 million prior to HCS’s liquidation, ensuring Masan retains its stake and potential upside from Nyobolt’s commercialization.

Market Context

MSR shares closed at VND 35,700 on July 29, 2026, on the UPCOM exchange. The stock has been under pressure due to the planned sale of H.C. Starck Holding and ongoing impairment charges. The partial reversal of Nyobolt provisions provides a positive catalyst, though the broader materials sector faces headwinds from global tungsten price volatility. Masan’s strategic shift toward high-tech materials and battery supply chain positions MSR as a niche player in the energy transition theme.

Strategic Significance

The Nyobolt investment underscores Masan’s strategy to leverage its tungsten expertise for high-growth applications in fast-charging batteries. Nyobolt’s technology, developed over 10 years by Cambridge University battery scientist Clare Grey, targets industrial EVs, robotics, consumer devices, and energy storage. The valuation increase validates the technology’s commercial potential and could lead to future gains for Masan if Nyobolt scales production. However, the partial impairment reversal suggests management remains cautious about near-term monetization.

What to Watch

• Nyobolt’s progress in securing additional commercial customers and production milestones.
• Any further valuation rounds or IPO plans for Nyobolt that could trigger additional impairment reversals.
• MSR’s Q3 2026 earnings report for updated impairment provisions and cash flow from the Nyobolt stake.
• Completion of H.C. Starck Holding sale and its impact on MSR’s balance sheet.
• Tungsten price trends and their effect on MSR’s core business margins.